Cadence OTC, founded in 2016, is a transformative player in the Biopharma, Medical Devices, and Pharmaceutical industries, headquartered in the United States. With the slogan "On a mission to increase access to safe, effective, affordable reproductive health products like MORNING AFTER PILL™️," the company seeks to revolutionize access to contraceptives.
By owning rights to three popular oral contraceptive formulations, Cadence OTC aims to make birth control pills available over-the-counter, eliminating the need for prescriptions or insurance. Their focus on healthcare accessibility extends to distributing emergency contraceptives in convenience stores nationwide, especially targeting healthcare deserts.
In its latest financial milestone, the company secured a $9.90M Series C investment on 01 February 2020. This investment reflects significant investor confidence in their mission to democratize access to reproductive health products.